Voriconazole: all 81 studies that test it
Page 1 of 1. Open to participants first (2), then studies with results posted, then the rest; newest registration first within each.
- Study on the Drug Interaction Between Buagafuran and VoriconazoleNot yet recruitingNCT07457203Phase 1
- Intralesional Voriconazole, or Intralesional Cryotherapy, or Oral Doxycycline in the Treatment of Cutaneous LeishmaniasisRecruitingNCT05708625Phase 3
- Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic SubjectsCompletedNCT04229303Phase 1Results posted
- Phase I Clinical Trial for Comparison of Pharmacokinetic Characteristics of Vorico Injection 200mg(Voriconazole) and Vfend® IV 200mg for Single Dose Crossover Intravenous Infusion in Healthy VolunteersCompletedNCT02631954Phase 1Results posted
- Drug-drug Interaction Trial of BI 113608 in Combination With Ketoconazole and Voriconazole in Healthy Male SubjectsCompletedNCT01787032Phase 1Results posted
- A Trial Comparing Efficacy and Safety of Voriconazole Administered With Therapeutic Drug Monitoring vs. Standard DosingCompletedNCT01416025Phase 4Results posted
- Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To Less Than 15 Years Old Who Are At High Risk For Systemic Fungal InfectionCompletedNCT01383993Phase 2Results posted
- Determine the Effects of Gene Differences and Voriconazole on Enzyme CYP2B6 Activity in the Liver in Healthy VolunteersCompletedNCT01104376Not applicableResults posted
- A Study Of The Safety, Tolerability And Effective Of Voriconazole For The Treatment Of Serious Candida Infection And Candida Infection Of The Throat In Pediatric PatientsTerminatedNCT01092832Phase 3Results posted
- Pharmacokinetics of Voriconazole in Obese SubjectsCompletedNCT01030653Phase 4Results posted
- The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole vs PlaceboCompletedNCT00997035Phase 3Results posted
- Mycotic Ulcer Treatment Trial ICompletedNCT00996736Phase 3Results posted
- A Study To Assess The Anidulafungin And Voriconazole Concentration In Lung Following Intravenous Administration In Healthy SubjectsCompletedNCT00940017Phase 4Results posted
- Beta Glucan Assay in Patients Receiving Voriconazole ProphylaxisCompletedNCT00904995Phase 3Results posted
- A Study To Evaluate The Safety Of Voriconazole As Treatment Of Invasive Aspergillosis (Fungal Infection) And Other Rare Molds In ChildrenTerminatedNCT00836875Phase 3Results posted
- Drug Interactions Between Voriconazole and Atazanavir Coadministered as Atazanavir/Ritonavir in Healthy ParticipantsCompletedNCT00833482Phase 1Results posted
- Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal InfectionCompletedNCT00739934Phase 2Results posted
- Anidulafungin Candidemia/Invasive Candidiasis Intensive Care StudyCompletedNCT00689338Phase 3Results posted
- Study to Test the Combination of Voriconazole and Anidulafungin in Patients Who Have, or Are Thought to Have, Invasive Aspergillosis and Who Are Unable to Take a Common Antifungal Therapy (Polyene)TerminatedNCT00620074Phase 4Results posted
- Therapeutic Exploratory Study of Comparing Natamycin and Voriconazole to Treat Fungal Corneal UlcerCompletedNCT00557362Phase 1/2Results posted
- A Multiple-Dose Study To Evaluate The Pharmacokinetics And Safety Of Voriconazole In Immunocompromised AdolescentsCompletedNCT00556998Phase 2Results posted
- This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive CandidiasisCompletedNCT00548262Phase 4Results posted
- Liposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal InfectionsCompletedNCT00418951Phase 2Results posted
- To Determine The Amount Of Voriconazole In The Brain After 2 Loading Doses And 3 Maintenance Doses Over 3 DaysCompletedNCT00300677Phase 4Results posted
- Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT)CompletedNCT00289991Phase 3Results posted
- Voriconazole and Caspofungin Acetate in Treating Invasive Fungal Infections in Patients With Weakened Immune SystemsTerminatedNCT00238355Phase 2Results posted
- Voriconazole For Chronic Bronchopulmonary AspergillosisCompletedNCT00159822Phase 2/3Results posted
- Immediate vs. Deferred Empirical Antifungal Treatment With Voriconazole In Neutropenic PatientsCompletedNCT00150345Phase 3Results posted
- Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell TransplantsCompletedNCT00143312Phase 4Results posted
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101)CompletedNCT00075803Phase 3Results posted
- A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy ParticipantsCompletedNCT06493409Phase 1
- A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary AspergillosisCompletedNCT04824417Phase 3
- Evaluate Bioequivalence of Voriconazole(200mg/Vial) .CompletedNCT04552353Phase 4
- A Study Evaluating Drug-Drug Interaction (DDI) Between HSK3486 Injectable Emulsion and Voriconazole TabletsCompletedNCT04145583Phase 1
- Three Induction Treatments on Cryptococcal MeningitisStatus unknownNCT04072640Early Phase 1
- Comparative Study of Human Immunodeficiency Virus Negative Host Talaromyces Between Voriconazole and Amphotericin Sequential Itraconazole TherapyStatus unknownNCT03827278Not applicable
- A Study to Evaluate the Appropriateness of the Voriconazole Dosing RegimenCompletedNCT03760276Phase 1
- A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Doses of Itraconazole and Voriconazole Are Given to Healthy VolunteersCompletedNCT03515382Phase 1
- Pharmacokinetics of Two Different Formulation of VoriconazoleCompletedNCT02912156Phase 4
- Influence of SLCO2B1 Polymorphism on the PK of Voriconazole in CYP2C19 PMCompletedNCT02906176Phase 1
- Pilot Study to Compare Topical Voriconazole to Placebo as a Pain Reducing AgentWithdrawnNCT02689713Phase 2
- Concentrations of Voriconazole in Blood and BAL-fluid After Inhalation and Oral AdministrationTerminatedNCT02396225Not applicable
- Amphotericin-B and Voriconazole for Pulmonary BlastomycosisTerminatedNCT02283905Phase 4
- Voriconazole for IPA in Chinese Patients With COPDStatus unknownNCT02234739Phase 4
- MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant PatientsCompletedNCT02227797Phase 1
- Evaluation of Budesonide and How It Interacts With Antifungal Drugs in People With Gastrointestinal Graft-Versus-Host DiseaseTerminatedNCT01950507Phase 1
- Individualisation of Voriconazole Antifungal Therapy Antifungal TherapySuspendedNCT01887457Phase 2
- Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend)CompletedNCT01657201Phase 1
- Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary AspergillosisCompletedNCT01621321Phase 2/3
- ATCF (Azole Therapy in Cystic Fibrosis)CompletedNCT01576315Phase 2
- Assessment of Target Site Pharmacokinetics of Voriconazole in Healthy Volunteers During Sequence TherapyCompletedNCT01539330Phase 4
- Effects of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Oral Buprenorphine: A Two-phase Cross-over Study in Healthy SubjectsCompletedNCT01466803Phase 1
- Effects of Posaconazole and Voriconazole on the Pharmacokinetics and Pharmacodynamics of Sublingual BuprenorphineCompletedNCT01367808Phase 1
- Population Pharmacokinetics of Anti-infectious Drugs in ChildrenCompletedNCT01344512Not applicable
- Trial of Combination Antifungal Therapy (Vori+Mica vs. Vori+Placebo) in Invasive AspergillosisWithdrawnNCT01207128Phase 2
- Influence of Drug-drug Interactions on the Pharmacokinetics (PK) of VoriconazoleCompletedNCT01080651Phase 1
- Influence of CYP2C19 Genotype on the Pharmacokinetics (PK) of VoriconazoleCompletedNCT00942773Phase 1
- Pharmacologic Optimization of VoriconazoleCompletedNCT00893555Phase 3
- Therapeutic Drug Monitoring of VoriconazoleCompletedNCT00890708Not applicable
- A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female AdultsCompletedNCT00855101Phase 1
- Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host DiseaseCompletedNCT00792246Phase 1
- A Study of the Efficacy and Safety of Voriconazole for the Treatment of Fungal InfectionsCompletedNCT00647907Phase 4
- Antifungal Prophylaxis in Pediatric Acute LeukemiaStatus unknownNCT00624143Phase 3
- Voriconazole as Prophylactic Therapy in Lung Transplant RecipientsTerminatedNCT00455364Phase 4
- A Study to Evaluate the Effectiveness of Voriconazole + Micafungin Versus Voriconazole Alone for Invasive AspergillosisWithdrawnNCT00423163Phase 4
- Antifungal Use in Oncohematological Neutropenic PatientsCompletedNCT00386802Phase 4
- A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal InfectionsCompletedNCT00288197Phase 4
- A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in ChildrenCompletedNCT00174473Phase 1/2
- Voriconazole or Placebo in the Prophylaxis of Lung Infiltrates in Patients Undergoing Induction Chemotherapy for Acute Myelogenous LeukemiaTerminatedNCT00152594Phase 3
- An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing With VfendTerminatedNCT00150319Phase 1/2
- Assessment of Voriconazole Penetration Into the Brain by Fluorine-Magnetic Resonance SpectroscopyCompletedNCT00136968Phase 1
- Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell TransplantationCompletedNCT00079222Not applicable
- Voriconazole in Preventing Fungal Infections in Children With Neutropenia After ChemotherapyCompletedNCT00066599Phase 2
- Voriconazole With or Without Interferon Gamma in Treating Patients With Aspergillosis or Other Fungal InfectionsCompletedNCT00059878Phase 2
- Emergency Use of Voriconazole in Patients With Life-Threatening Invasive Fungal InfectionsCompletedNCT00015665Phase 3
- Voriconazole to Prevent Systemic Fungal Infections in ChildrenCompletedNCT00005912Phase 1
- Comparison of Voriconazole and Amphotericin B in Treating Patients With AspergillosisCompletedNCT00003031Phase 3
- Voriconazole to Treat Fungal InfectionsCompletedNCT00001940Phase 3
- An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsCompletedNCT00001810Phase 3
- An Open Label, Non-Comparative, Multicenter, Phase III Trial of the Efficacy, Safety and Toleration of Voriconazole in the Primary or Secondary Treatment of Invasive Fungal InfectionsCompletedNCT00001757Phase 3
- Voriconazole vs. Amphotericin B in the Treatment of Invasive AspergillosisCompletedNCT00001646Phase 3